✦ LIBER ✦

IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

✍ Scribed by Nicola Cahill; Lesley-Ann Sutton; Mattias Jansson; Fiona Murray; Larry Mansouri; Rebeqa Gunnarsson; Fergus Ryan; Karin E. Smedby; Christian Geisler; Gunnar Juliusson; Richard Rosenquist

Book ID: 119219028
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 411 KB
Volume: 12
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3.12 The Prevalence of Serious Infection

3.12 The Prevalence of Serious Infections in a Community-Based Cohort of Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

✍ Jonathan Moreira; Kari Rabe; James R. Cerhan; John Wilson; Neil Kay; Clive Zent; 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 292 KB

Risk of mortality in a cohort of patient

Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation

✍ Ana Ruigómez; Saga Johansson; Mari-Ann Wallander; Luis Alberto García Rodríguez 📂 Article 📅 2002 🏛 BioMed Central 🌐 English ⚖ 407 KB

Prognostic importance of T and NK-cells

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

✍ Shanique Palmer; Curtis A. Hanson; Clive S. Zent; Luis F. Porrata; Betsy LaPlant 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Identification of a novel, transactivati

Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia

✍ Sona Pekova; Radek Cmejla; Lukas Smolej; Tomas Kozak; Martin Spacek; Miroslav Pr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 567 KB

p53 is implemented in many processes controlling cell fate. Recently it has been reported that besides post-translational modifications and regulation of protein-protein interactions, the activity of p53 is also substantially controlled at transcriptional level. In 109 out of 127 (86%) patients with

A phase II study of continuous infusion

A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804

✍ Richard M. Stone; Kathleen A. Donohue; Wendy Stock; Vera Hars; Charles A. Linker 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 281 KB

The high frequency of T regulatory cells

The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide

✍ Giannopoulos, K; Schmitt, M; Własiuk, P; Chen, J; Bojarska-Junak, A; Kowal, M; R 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB